tradingkey.logo
tradingkey.logo
Search

Plus Therapeutics Inc

PSTV
Add to Watchlist
3.870USD
+0.220+6.03%
Close 07-31 16:00ETQuotes delayed by 15 min
1.06MMarket Cap
LossP/E TTM

PSTV Financials

See Plus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Plus Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-26.13/-0.88
Revenue / Forecast
1.03M/974.00K
Period
FY2025 Earnings
Revenue(YoY)
5.21M
-10.49%
EPS(YoY)
-7.19
85.28%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-2087.27%-26.13
-109.01%-1.04
88.75%-0.04
123.54%0.11
-58.31%-1.19
41.40%-0.50
63.34%-0.37
23.42%-0.45
63.57%-0.75
66.42%-0.85
---1.00
---0.59
---2.07
---2.52
---9.22
----
----
----
----
----
Revenue
-2.93%1.03M
-3.19%1.37M
-4.05%1.40M
8.68%1.39M
-36.85%1.06M
7.54%1.41M
17.42%1.46M
-31.01%1.28M
231.42%1.68M
769.54%1.31M
1598.63%1.24M
--1.85M
--506.00K
--151.00K
--73.00K
----
----
--0.00
--0.00
-100.00%0.00
Net Profit
60.08%-6.95M
-46.37%-5.71M
-53.90%-4.42M
275.20%5.15M
-433.61%-17.40M
-2.44%-3.90M
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.80M
-36.17%-5.66M
-40.15%-5.22M
-88.64%-5.28M
-51.32%-4.12M
-15.83%-4.16M
-115.51%-3.72M
-52.26%-2.80M
Net Margin
58.88%-675.68%
-51.19%-417.92%
-60.40%-316.61%
261.21%370.58%
-745.01%-1643.15%
4.74%-276.42%
23.96%-197.39%
-187.57%-229.87%
79.52%-194.45%
92.26%-290.18%
---259.60%
---79.94%
---949.60%
---3747.02%
---20023.29%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--3.35%
-90.74%4.59%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
42.15%49.63%
44.07%47.18%
-11.48%29.36%
97.50%63.87%
54.48%34.91%
--32.75%
--33.17%
--32.34%
--22.60%
--24.74%
----
----
----
----
----
Revenue
-2.93%1.03M
-3.19%1.37M
-4.05%1.40M
8.68%1.39M
-36.85%1.06M
7.54%1.41M
17.42%1.46M
-31.01%1.28M
231.42%1.68M
769.54%1.31M
1598.63%1.24M
--1.85M
--506.00K
--151.00K
--73.00K
----
----
--0.00
--0.00
-100.00%0.00
Operating profit
-101.33%-7.12M
-47.23%-5.74M
-17.98%-4.48M
58.40%-1.54M
-7.18%-3.54M
-1.04%-3.90M
-16.86%-3.80M
-148.12%-3.70M
30.11%-3.30M
30.73%-3.86M
36.18%-3.25M
70.90%-1.49M
-20.22%-4.72M
-53.03%-5.57M
-46.34%-5.09M
-98.83%-5.12M
-58.37%-3.93M
-7.25%-3.64M
-149.36%-3.48M
-63.91%-2.58M
Net Profit
60.08%-6.95M
-46.37%-5.71M
-53.90%-4.42M
275.20%5.15M
-433.61%-17.40M
-2.44%-3.90M
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.80M
-36.17%-5.66M
-40.15%-5.22M
-88.64%-5.28M
-51.32%-4.12M
-15.83%-4.16M
-115.51%-3.72M
-52.26%-2.80M
Current assets
65.88%18.03M
188.46%15.17M
227.85%17.59M
-1.77%9.21M
157.96%10.87M
-46.52%5.26M
-53.69%5.36M
-24.13%9.38M
-69.09%4.21M
-54.93%9.83M
-44.52%11.58M
-34.54%12.36M
-38.34%13.63M
10.61%21.82M
-5.51%20.88M
4.93%18.89M
43.11%22.10M
114.98%19.72M
155.49%22.10M
66.78%18.00M
Total current liabilities
-24.66%7.96M
-20.82%12.31M
12.42%13.62M
-61.06%7.32M
1.54%10.56M
44.97%15.55M
14.94%12.11M
64.81%18.79M
-18.73%10.40M
-9.49%10.73M
42.02%10.54M
63.52%11.40M
160.03%12.80M
101.91%11.85M
-21.80%7.42M
-16.55%6.97M
-40.82%4.92M
-31.26%5.87M
12.90%9.49M
-14.52%8.35M
Total assets
65.20%19.92M
146.12%16.32M
167.56%18.67M
-7.69%10.35M
114.48%12.06M
-41.75%6.63M
-47.45%6.98M
-21.03%11.21M
-64.06%5.62M
-52.29%11.39M
-42.53%13.28M
-33.26%14.20M
-36.21%15.64M
8.58%23.87M
-6.65%23.10M
2.10%21.27M
33.70%24.52M
81.59%21.98M
112.39%24.75M
49.84%20.83M
Total liabilities
-77.72%7.96M
-20.88%12.33M
12.05%13.62M
-61.16%7.32M
241.34%35.70M
22.35%15.58M
14.04%12.15M
63.30%18.84M
-19.32%10.46M
-26.90%12.74M
-8.92%10.66M
-0.49%11.54M
31.27%12.96M
56.32%17.42M
17.06%11.70M
30.41%11.59M
11.91%9.87M
22.82%11.14M
10.66%9.99M
-16.17%8.89M
Total equity
150.59%11.96M
144.65%4.00M
197.68%5.05M
139.79%3.03M
-388.75%-23.64M
-563.87%-8.95M
-297.33%-5.17M
-386.44%-7.63M
-280.75%-4.84M
-120.92%-1.35M
-77.01%2.62M
-72.50%2.66M
-81.72%2.68M
-40.52%6.45M
-22.71%11.40M
-18.97%9.68M
53.92%14.64M
257.51%10.84M
462.95%14.76M
261.97%11.95M
Net operating income
-1.07%-6.24M
-416.68%-6.26M
30.76%-2.55M
-404.17%-5.80M
-36.76%-6.17M
35.62%-1.21M
-53.40%-3.68M
58.60%-1.15M
22.10%-4.51M
15.80%-1.88M
43.18%-2.40M
-5.23%-2.78M
-49.46%-5.79M
14.86%-2.23M
-87.56%-4.22M
-10.05%-2.64M
-28.94%-3.88M
18.61%-2.62M
2.09%-2.25M
-70.26%-2.40M
Net investment
-339.83%-8.53M
-1782.81%-1.08M
14511.11%1.30M
-21.83%-4.63M
1077.47%3.56M
252.38%64.00K
10.00%-9.00K
-34463.64%-3.80M
-275.26%-364.00K
-281.82%-42.00K
69.70%-10.00K
92.03%-11.00K
83.19%-97.00K
-650.00%-11.00K
-725.00%-33.00K
-3550.00%-138.00K
-586.90%-577.00K
103.57%2.00K
71.43%-4.00K
100.97%4.00K
Net financing
-27.17%9.04M
--2.80M
--12.31M
-59.84%2.80M
1698.58%12.40M
100.00%0.00
-100.00%0.00
624.56%6.96M
-257.40%-776.00K
-634.34%-529.00K
-60.81%2.52M
359.03%961.00K
-93.24%493.00K
138.37%99.00K
0.89%6.43M
-107.26%-371.00K
-20.66%7.29M
-106.45%-258.00K
847.10%6.37M
202.71%5.11M

FAQs

What is the total revenue of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its total revenue reached 5.21M, with a year-on-year change of 5.82M.

What are the current assets of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its current assets were 15.17M, with a year-on-year change of 188.46.

What are the total assets of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its total assets of Plus Therapeutics Inc were 16.32M, with a year-on-year change of 146.12.

What are the total liabilities of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its total liabilities of Plus Therapeutics Inc were 12.33M, with a year-on-year change of -20.88.

What is the total equity of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its total equity of Plus Therapeutics Inc was 4.00M, with a year-on-year change of 144.65.

What is the net operating income of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its net operating income of Plus Therapeutics Inc was -15.30M, with a year-on-year change of -4.10.

What is the net investment of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its net investment of Plus Therapeutics Inc was -854.00K, with a year-on-year change of 79.23.

What is the net financing of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its net financing of Plus Therapeutics Inc was 30.31M, with a year-on-year change of 389.91.

What is the Earnings Per Share (EPS) of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -7.19, with a year-on-year change of 85.28.

What is the net income of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its net income was -22.39M, with a year-on-year change of -72.49.

What is the net margin of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its net profit margin was -429.43, with a year-on-year change of -92.71.

What is the debt-to-asset ratio of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 4.59, with a year-on-year change of -90.74.

What is the Return on Assets (ROA) of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -195.02, with a year-on-year change of -35.40.

What is the operating profit of Plus Therapeutics Inc?

According to Plus Therapeutics Inc's FY2025 earnings report, its operating profit was -15.30M, with a year-on-year change of -4.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.